Lipofectamine MessengerMAX Transfection Reagent, 0.1 mL and 1 more item

The University of Virginia awarded contract A207_PO-0486937 to Life Technologies Corporation, effective October 1, 2026. The cumulative contract value totals $239. While specific details regarding the products and services to be delivered under this award are not provided in the available documentation, Life Technologies Corporation's primary business operations encompass life sciences research tools, including laboratory equipment, reagents, and analytical instruments. The contracting organization is the University of Virginia, a major research institution in the Commonwealth of Virginia.

The contract documentation does not specify the period of performance, place of performance, or detailed scope of work. No annual value or total contract amount separate from the cumulative value of $239 is indicated in the available materials. To obtain comprehensive information regarding deliverables, performance schedules, and specific technical requirements, reference to the complete contract documentation would be necessary.